Similar articles

• Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial.

  Sotelo J, Briceño E, López-González MA. Sotelo J, et al. Ann Intern Med. 2006 Mar 7;144(5):337-43. doi: 10.7326/0003-4819-144-5-200603070-00008. Ann Intern Med. 2006. PMID: 16520474 Clinical Trial.
• New treatments for malignant gliomas: careful evaluation and cautious optimism required.

  Gilbert MR. Gilbert MR. Ann Intern Med. 2006 Mar 7;144(5):371-3. doi: 10.7326/0003-4819-144-5-200603070-00015. Ann Intern Med. 2006. PMID: 16520480 No abstract available.
• Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine.

  Briceño E, Reyes S, Sotelo J. Briceño E, et al. Neurosurg Focus. 2003 Feb 15;14(2):e3. doi: 10.3171/foc.2003.14.2.4. Neurosurg Focus. 2003. PMID: 15727424 Clinical Trial.
• The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.

  Dixit S, Hingorani M, Achawal S, Scott I. Dixit S, et al. Br J Neurosurg. 2011 Aug;25(4):459-69. doi: 10.3109/02688697.2010.550342. Epub 2011 Feb 23. Br J Neurosurg. 2011. PMID: 21344976 Review.
• Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.

  Roa W, Xing JZ, Small C, Kortmann R, Miriamanoff R, Okunieff P, Shibamoto Y, Jeremic B. Roa W, et al. Expert Rev Anticancer Ther. 2009 Nov;9(11):1643-50. doi: 10.1586/era.09.128. Expert Rev Anticancer Ther. 2009. PMID: 19895247 Review.